Starling Oncology Institute Inc (STLN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -12,281 | -2,492 | -60,606 | -53,098 | -36,594 |
| Depreciation Amortization | 5,921 | 2,827 | 15,324 | 12,487 | 9,592 |
| Income taxes - deferred | 0 | N/A | -32 | -32 | -32 |
| Accounts receivable | -7,351 | 864 | -12,308 | -12,949 | -8,969 |
| Accounts payable and accrued liabilities | 17,112 | 4,611 | 19,638 | 11,929 | 11,490 |
| Other Working Capital | 15,228 | 928 | 1,325 | -6,328 | -156 |
| Other Operating Activity | -8,904 | -8,953 | 12,072 | 20,171 | 9,479 |
| Operating Cash Flow | $9,725 | $-2,215 | $-24,587 | $-27,820 | $-15,190 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,950 | -1,042 | -3,200 | -2,140 | -1,536 |
| Other Investing Activity | 0 | 0 | 126 | 126 | 126 |
| Investing Cash Flow | $-1,950 | $-1,042 | $-3,074 | $-2,014 | $-1,410 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -17 | -9 | -20,037 | -20,028 | -20,020 |
| Common Stock Issued | 331 | 241 | 32,635 | 28,542 | 17,699 |
| Other Financing Activity | -560 | -260 | -1,041 | -691 | -456 |
| Financing Cash Flow | $-246 | $-28 | $11,557 | $7,823 | $-2,777 |
| Beginning Cash Position | 33,565 | 33,565 | 49,669 | 49,669 | 49,669 |
| End Cash Position | 41,094 | 30,280 | 33,565 | 27,658 | 30,292 |
| Net Cash Flow | $7,529 | $-3,285 | $-16,104 | $-22,011 | $-19,377 |
| Free Cash Flow | |||||
| Operating Cash Flow | 9,725 | -2,215 | -24,587 | -27,820 | -15,190 |
| Capital Expenditure | -1,950 | -1,042 | -3,200 | -2,140 | -1,536 |
| Free Cash Flow | 7,775 | -3,257 | -27,787 | -29,960 | -16,726 |